Enzo Biochem

ENZ49

Penny Stock

$1.04arrow_drop_down10.08%-$0.11

Penny Stock

ENZ49

$1.04

arrow_drop_down10.08%-$0.11

Penny Stock

Performance History

Key Stats
Open	$1.10
Prev. Close	$1.14
EPS	-0.17

Next Earnings Date	-
Dividend Yield %	-
Market Cap	$54.33M
PE Ratio	-

	LOW	HIGH
Day Range	1.00	1.14
52 Week Range	0.99	1.50

Ratios







EPS	-0.17

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Enzo Biochem (ENZ)

Enzo Biochem Inc (ENZ) is a leading biotechnology company that specializes in the development, manufacture, and sale of innovative diagnostic and research tools. With over 40 years of experience in the industry, Enzo Biochem has established itself as a trusted provider of high-quality products and services to the global life sciences community. The company's portfolio includes a wide range of products, including assays, reagents, and instruments, that are used in various applications, such as clinical diagnostics, drug discovery, and genetic research.

One of the key strengths of Enzo Biochem is its strong focus on research and development. The company invests heavily in cutting-edge technologies and collaborates with leading academic institutions and industry partners to drive innovation. This commitment to R&D has enabled Enzo Biochem to consistently introduce new products and improve existing ones, keeping it at the forefront of the rapidly evolving life sciences industry. In addition, the company has a robust intellectual property portfolio, which further supports its competitive advantage.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Mr. Hamid Erfanian
Headquarters: Farmingdale
Employees: 465
Exchange: NYSE

Keep an eye on Enzo Biochem

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Enzo Biochem 's (ENZ) price per share?

The current price per share for Enzo Biochem (ENZ) is $1.04. The stock has seen a price change of -$0.11 recently, indicating a -10.09% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Enzo Biochem (ENZ)?

For Enzo Biochem (ENZ), the 52-week high is $1.5, which is 44.23% from the current price. The 52-week low is $0.99, the current price is 5.05% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Enzo Biochem (ENZ) a growth stock?

Enzo Biochem (ENZ) has shown an average price growth of -6.65% over the past three years. It has received a score of 13 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Enzo Biochem as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Enzo Biochem (ENZ) stock price performance year to date (YTD)?

As of the latest data, Enzo Biochem (ENZ) has a year-to-date price change of -30.67%. Over the past month, the stock has experienced a price change of -7.96%. Over the last three months, the change has been -7.96%. Over the past six months, the figure is -6.31%. Looking at a longer horizon, the five-year price change stands at -63.51%.

help

Is Enzo Biochem (ENZ) a profitable company?

Enzo Biochem (ENZ) has a net income of -$26.08M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 45.86% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -38.75% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $31.91M, with a revenue growth rate of 2.72%, providing insight into the company's sales performance and growth. The gross profit is $14.63M. Operating income is noted at -$9.82M. Furthermore, the EBITDA is -$11.09M.

help

What is the market capitalization of Enzo Biochem (ENZ)?

Enzo Biochem (ENZ) has a market capitalization of $54.33M. The average daily trading volume is 1.04, indicating the stock's liquidity and investor engagement.